Discovering DNA: Friedrich Miescher and the early years of nucleic acid research. Human Genetics, 122(6), 565-581

Center for Brain Research, Medical University of Vienna, Spitalgasse 4, 1090, Vienna, Austria,
Human Genetics (Impact Factor: 4.82). 02/2008; 122(6):565-81. DOI: 10.1007/s00439-007-0433-0
Source: PubMed


In the winter of 1868/9 the young Swiss doctor Friedrich Miescher, working in the laboratory of Felix Hoppe-Seyler at the University of Tübingen, performed experiments on the chemical composition of leukocytes that lead to the discovery of DNA. In his experiments, Miescher noticed a precipitate of an unknown substance, which he characterised further. Its properties during the isolation procedure and its resistance to protease digestion indicated that the novel substance was not a protein or lipid. Analyses of its elementary composition revealed that, unlike proteins, it contained large amounts of phosphorous and, as Miescher confirmed later, lacked sulphur. Miescher recognised that he had discovered a novel molecule. Since he had isolated it from the cells' nuclei he named it nuclein, a name preserved in today's designation deoxyribonucleic acid. In subsequent work Miescher showed that nuclein was a characteristic component of all nuclei and hypothesised that it would prove to be inextricably linked to the function of this organelle. He suggested that its abundance in tissues might be related to their physiological status with increases in "nuclear substances" preceding cell division. Miescher even speculated that it might have a role in the transmission of hereditary traits, but subsequently rejected the idea. This article reviews the events and circumstances leading to Miescher's discovery of DNA and places them within their historic context. It also tries to elucidate why it was Miescher who discovered DNA and why his name is not universally associated with this molecule today.

Download full-text


Available from: Ralf Dahm
  • Source
    • "Natural genes principally encode proteins [1]. We previously proposed a novel artificial gene-based biocomputing model enabling digitally compressed imaging data to be stored in editable DNA molecules [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We previously proposed novel designs for artificial genes as media for storing digitally compressed image data, specifically for biocomputing by analogy to natural genes mainly used to encode proteins. A run-length encoding (RLE) rule had been applied in DNA-based image data processing, to form coding regions, and noncoding regions were created as space for designing biochemical editing. In the present study, we apply the RLE-based image-coding rule to creation of DNA-based animation. This article consisted of three parts: (i) a theoretical review of RLE-based image coding by DNA, (ii) a technical proposal for biochemical editing of DNA-coded images using the polymerase chain reaction, and (iii) a minimal demonstration of DNA-based animation using simple model images encoded on short DNA molecules.
    Full-text · Article · Jan 2015 · Journal of Advanced Computational Intelligence and Intelligent Informatics
  • Source
    • "In the winter of 1868/69 DNA (deoxyribonucleic acid) was first isolated by the Swiss doctor Friedrich Miescher who performed experiments on the chemical composition of leukocytes. Since he isolated a novel molecule from the cells`nuclei he named it nuclein [1]. Fifty years later, Phoebus Levene identified the base, sugar and phosphate nucleotide unit [2] and in 1924 Hammarsten reported that metal cations are needed in cells to help neutralize the negative charge of DNA [3] . "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this review several types of interactions between metal ions and DNA are given, starting from basic binding to the use of metal complexes in cancer treatment and diagnostics. Metal cations help to neutralize the negative charge of DNA and thus enable the normal functions of DNA but many other interactions are also possible and are discussed in this paper. Various consequences of such interactions can be reversible (e. g. conformational changes) or irreversible (e. g. cleavage). It is known that some metal ions can also damage DNA which can provoke mutations and in some cases leads to cancer. It is clear that we know a lot about metal-DNA interactions but much more information is needed to understand the role of metal ions completely and to use this knowledge successfully.
    Full-text · Article · Nov 2011 · Current topics in medicinal chemistry
  • [Show abstract] [Hide abstract]
    ABSTRACT: Since nucleic acids (DNA and RNA) play very important roles in cells, they are molecular targets of many clinically used drugs, such as anticancer drugs and antibiotics. Because of clinical demands for treating various deadly cancers and drug-resistant strains of pathogens, there are urgent needs to develop novel therapeutic agents. Targeting nucleic acids hasn’t been the mainstream of drug discovery in the past, and the lack of 3D structural information for designing and developing drug specificity is one of the main reasons. Fortunately, many important structures of nucleic acids and their protein complexes have been determined over the past decade, which provide novel platforms for future drug design and discovery. In this review, we describe some useful nucleic acid structures, particularly their interactions with the ligands and therapeutic candidates or even drugs. We summarize important information for designing novel potent drugs and for targeting nucleic acids and protein-nucleic acid complexes to treat cancers and overcome the drug-resistant problems. Kewyordsnucleic acid targets–DNA and RNA–protein-nucleic acid complexes–DNA duplex and junction–G-quadruplex–ribozyme–riboswitch–ribosome–topoisomerase–inhibitors–antibiotics–structure-based drug design–therapeutic agents
    No preview · Article · Jan 2011 · Science China-Chemistry
Show more